IDDF2021-ABS-0078 Switching from tenofovir disoproxil fumarate (TDF) and/or other oral antivirals (OAVS) to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with moderate or severe renal impairment, or with end-stage renal disease (ESRD)
Harry LA Janssen
◽
Pietro Lampertico
◽
Chien-Hung Chen
◽
Jeong Heo
◽
Claire Fournier
◽
...
2018 ◽
Vol 63
(5)
◽
pp. 1334-1340
◽
Sunil Taneja
◽
Ajay Duseja
◽
Arka De
◽
Manu Mehta
◽
Raja Ramachandran
◽
...
2014 ◽
Vol 80
(4)
◽
pp. 327-329
◽
Steven L. Barriere
◽
David J. Farrell
◽
Paul R. Rhomberg
◽
Ronald N. Jones
2015 ◽
Vol 62
◽
pp. S257
◽
P.J. Pockros
◽
K.R. Reddy
◽
P.S. Mantry
◽
E. Cohen
◽
M. Bennett
◽
...
2005 ◽
Vol &NA;
(1494)
◽
pp. 19
2010 ◽
Vol 39
(9)
◽
pp. 397-400
◽
Ezequiel Ridruejo
◽
Raúl Adrover
◽
Cristina Alonso
◽
Oscar G. Mandó
◽
Marcelo O. Silva
2016 ◽
Vol 64
(2)
◽
pp. S813
◽
R.M. Gómez
◽
D. Rincón
◽
E. Hernández
◽
A. Ahumada
◽
M.D. Pérez Valderas
◽
...
2016 ◽
Vol 174
(5)
◽
pp. 748-759
◽
Neeraj Gupta
◽
Michael J. Hanley
◽
R. Donald Harvey
◽
Ashraf Badros
◽
Brea Lipe
◽
...
2015 ◽
Vol 56
(4)
◽
pp. 474-483
◽
Marion Dahlke
◽
Atef Halabi
◽
Jasna Canadi
◽
Chiaki Tsubouchi
◽
Surendra Machineni
◽
...
2017 ◽
Vol 31
(16)
◽
pp. 2314-2315
◽
Alessandra Tartaglia
◽
Sergio Maria Ferrara
◽
Salvatore Sica
◽
Teresa Santantonio
2018 ◽
Vol 43
(2)
◽
pp. 594-605
◽
Jan Sperl
◽
Miluse Kreidlova
◽
Dusan Merta
◽
Klara Chmelova
◽
Renata Senkerikova
◽
...
Close
Export Citation Format
Close
Share Document
Close